![](/sites/default/files/styles/img_search_list_desktop/public/en_2017_annual_results_format_resource_library_.jpg?h=de586304&itok=LYN-6Mgw)
2017 Annual Results
SCOR has been named “Reinsurer of the Year” for 2017 by InsuranceERM
SCOR has completed the increase of its stake in MutRé S.A. to 100%.
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
SCOR was honored twice at Reactions magazine’s North American Awards, during a ceremony held in New York on September 28, 2017.
One year after the launch of its new three-year strategic plan, SCOR has successfully executed the first phase of “Vision in Action”.